These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

860 related items for PubMed ID: 26175357

  • 1. Comparing Guidelines for Statin Treatment in Canada and the United States.
    Hennessy DA, Bushnik T, Manuel DG, Anderson TJ.
    J Am Heart Assoc; 2015 Jul 14; 4(7):. PubMed ID: 26175357
    [Abstract] [Full Text] [Related]

  • 2. Increases in statin eligibility to reduce cardiovascular risk according to the 2013 ACC/AHA cholesterol guidelines in the Africa Middle East region: a sub-analysis of the Africa Middle East Cardiovascular Epidemiological (ACE) study.
    Hamoui O, Omar MI, Raal FJ, Rashed W, Kane A, Alami M, Abreu P, Mashhoud W, Alsheikh-Ali AA.
    BMC Cardiovasc Disord; 2019 Mar 15; 19(1):61. PubMed ID: 30876390
    [Abstract] [Full Text] [Related]

  • 3. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.
    Akhabue E, Rittner SS, Carroll JE, Crawford PM, Dant L, Laws R, Leo MC, Puro J, Persell SD.
    J Am Heart Assoc; 2017 Jul 03; 6(7):. PubMed ID: 28673901
    [Abstract] [Full Text] [Related]

  • 4. American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular Risk: Implications for US Hispanics/Latinos Based on Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
    Qureshi WT, Kaplan RC, Swett K, Burke G, Daviglus M, Jung M, Talavera GA, Chirinos DA, Reina SA, Davis S, Rodriguez CJ.
    J Am Heart Assoc; 2017 May 11; 6(5):. PubMed ID: 28495699
    [Abstract] [Full Text] [Related]

  • 5. Validation of the 2016 USPSTF recommendations for primary cardiovascular prevention in a large contemporary cohort.
    Schonmann Y, Bleich O, Matalon A, Yeshua H.
    Eur J Prev Cardiol; 2018 May 11; 25(8):870-880. PubMed ID: 29517367
    [Abstract] [Full Text] [Related]

  • 6. Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan.
    Olufade T, Zhou S, Anzalone D, Kern DM, Tunceli O, Cziraky MJ, Willey VJ.
    J Am Heart Assoc; 2017 May 04; 6(5):. PubMed ID: 28473405
    [Abstract] [Full Text] [Related]

  • 7. Statin eligibility and cardiovascular risk burden assessed by coronary artery calcium score: comparing the two guidelines in a large Korean cohort.
    Rhee EJ, Park SE, Oh HG, Park CY, Oh KW, Park SW, Blankstein R, Plutzky J, Lee WY.
    Atherosclerosis; 2015 May 04; 240(1):242-9. PubMed ID: 25818250
    [Abstract] [Full Text] [Related]

  • 8. Comparison of Recommended Eligibility for Primary Prevention Statin Therapy Based on the US Preventive Services Task Force Recommendations vs the ACC/AHA Guidelines.
    Pagidipati NJ, Navar AM, Mulder H, Sniderman AD, Peterson ED, Pencina MJ.
    JAMA; 2017 Apr 18; 317(15):1563-1567. PubMed ID: 28418481
    [Abstract] [Full Text] [Related]

  • 9. Applicability and potential clinical effects of 2013 cholesterol guidelines on major cardiovascular events.
    Ko MJ, Kim YJ, Park CM, Lee SM, Lee WJ, Pencina MJ, Navar-Boggan AM, Park DW.
    Am Heart J; 2015 Sep 18; 170(3):598-605.e7. PubMed ID: 26385045
    [Abstract] [Full Text] [Related]

  • 10. Time to improve statin prescription guidelines in low-risk patients?
    Balder JW, de Vries JK, Mulder DJ, Kamphuisen PW.
    Eur J Prev Cardiol; 2017 Jul 18; 24(10):1064-1070. PubMed ID: 28429651
    [Abstract] [Full Text] [Related]

  • 11. Comparison of ACC/AHA and ESC Guideline Recommendations Following Trial Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: Results From the Population-Based Rotterdam Study.
    Pavlovic J, Greenland P, Deckers JW, Brugts JJ, Kavousi M, Dhana K, Ikram MA, Hofman A, Stricker BH, Franco OH, Leening MJ.
    JAMA Cardiol; 2016 Sep 01; 1(6):708-13. PubMed ID: 27439175
    [Abstract] [Full Text] [Related]

  • 12. Increased statin eligibility based on ACC/AHA versus NCEP guidelines for high cholesterol management in Chile.
    Echeverría G, Dussaillant C, Villarroel L, Rigotti A.
    J Clin Lipidol; 2016 Sep 01; 10(1):192-8.e1. PubMed ID: 26892136
    [Abstract] [Full Text] [Related]

  • 13. Population health impact of statin treatment in Canada.
    Hennessy DA, Tanuseputro P, Tuna M, Bennett C, Perez R, Shields M, Ko DT, Tu J, Manuel DG.
    Health Rep; 2016 Jan 20; 27(1):20-8. PubMed ID: 26788719
    [Abstract] [Full Text] [Related]

  • 14. CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines.
    Mahabadi AA, Möhlenkamp S, Lehmann N, Kälsch H, Dykun I, Pundt N, Moebus S, Jöckel KH, Erbel R, Heinz Nixdorf Recall Study Investigators.
    JACC Cardiovasc Imaging; 2017 Feb 20; 10(2):143-153. PubMed ID: 27665163
    [Abstract] [Full Text] [Related]

  • 15. Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events.
    Pursnani A, Massaro JM, D'Agostino RB, O'Donnell CJ, Hoffmann U.
    JAMA; 2015 Jul 14; 314(2):134-41. PubMed ID: 26172893
    [Abstract] [Full Text] [Related]

  • 16. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.
    Kavousi M, Leening MJ, Nanchen D, Greenland P, Graham IM, Steyerberg EW, Ikram MA, Stricker BH, Hofman A, Franco OH.
    JAMA; 2014 Apr 09; 311(14):1416-23. PubMed ID: 24681960
    [Abstract] [Full Text] [Related]

  • 17. Use of Statins for Primary Prevention: Selection of Risk Threshold and Implications Across Race and Gender.
    Goyal A, Cooper HA, Aronow WS, Nagpal P, Yandrapalli S, Nabors CC, Frishman WH.
    Am J Med; 2018 Oct 09; 131(10):1234-1237. PubMed ID: 29928863
    [Abstract] [Full Text] [Related]

  • 18. Comparing eligibility for statin therapy for primary prevention under 2022 USPSTF recommendations and the 2018 AHA/ACC/ multi-society guideline recommendations: From National Health and Nutrition Examination Survey.
    Gupta K, Kakar TS, Jain V, Gupta M, Al Rifai M, Slipczuk L, Nambi V, Bittner V, Blumenthal RS, Stone NJ, Lavie CJ, Virani SS.
    Prog Cardiovasc Dis; 2022 Oct 09; 75():78-82. PubMed ID: 36038004
    [Abstract] [Full Text] [Related]

  • 19. Statin Eligibility, Coronary Artery Calcium, and Subsequent Cardiovascular Events According to the 2016 United States Preventive Services Task Force (USPSTF) Statin Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).
    Miedema MD, Dardari ZA, Kianoush S, Virani SS, Yeboah J, Knickelbine T, Sandfort V, Rodriguez CJ, Nasir K, Blaha MJ.
    J Am Heart Assoc; 2018 Jun 13; 7(12):. PubMed ID: 29899017
    [Abstract] [Full Text] [Related]

  • 20. Sex Differences in the Use of Statins in Community Practice.
    Nanna MG, Wang TY, Xiang Q, Goldberg AC, Robinson JG, Roger VL, Virani SS, Wilson PWF, Louie MJ, Koren A, Li Z, Peterson ED, Navar AM.
    Circ Cardiovasc Qual Outcomes; 2019 Aug 13; 12(8):e005562. PubMed ID: 31416347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.